Sphingosine 1 Phosphate Receptor Modulators

DBCAT005548Pharmacologic class

Agents that affect the function of G-protein coupled SPHINGOSINE 1-PHOSPHATE RECEPTORS. Their binding to the receptors blocks lymphocyte migration and are often used as IMMUNOSUPPRESSANTS. A DrugBank category of 5 drugs. 4 of them are approved.

Drugs: Ceralifimod
Fingolimod
Ozanimod
Ponesimod
Siponimod

What you can answer from here — as of January 08, 2022

5DrugsEach linked to its full drug card

Listed above

7Drug targetsEvery drug–target pair in the class, with bond type

356Marketed productsAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do Sphingosine 1 Phosphate Receptor Modulators share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account